| PERIOD ENDING | 3-Jan-09 | 29-Dec-07 | 30-Dec-06 | | Total Revenue | 4,363,251 | 3,779,277 | 3,302,447 | | Cost of Revenue | 1,170,541 | 1,041,594 | 913,513 | | | Gross Profit | 3,192,710 | 2,737,683 | 2,388,934 | | | Operating Expenses | | Research Development | 531,799 | 476,332 | 431,102 | | Selling General and Administrative | 1,636,526 | 1,382,466 | 1,195,030 | | Non Recurring | 369,338 | 85,382 | 19,719 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 655,047 | 793,503 | 743,083 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,725) | (10,969) | 11,441 | | Earnings Before Interest And Taxes | 653,322 | 782,534 | 754,524 | | Interest Expense | 22,581 | 38,229 | 33,883 | | Income Before Tax | 630,741 | 744,305 | 720,641 | | Income Tax Expense | 246,414 | 185,267 | 172,390 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 384,327 | 559,038 | 548,251 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 384,327 | 559,038 | 548,251 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $384,327 | $559,038 | $548,251 |
|
1.48% Nasdaq 
Income Statement
